These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38457001)

  • 1. Osteocytes and Paget's Disease of Bone.
    Tenshin H; Delgado-Calle J; Windle JJ; Roodman GD; Chirgwin JM; Kurihara N
    Curr Osteoporos Rep; 2024 Apr; 22(2):266-272. PubMed ID: 38457001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
    Neale SD; Smith R; Wass JA; Athanasou NA
    Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
    J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.
    Menaa C; Reddy SV; Kurihara N; Maeda H; Anderson D; Cundy T; Cornish J; Singer FR; Bruder JM; Roodman GD
    J Clin Invest; 2000 Jun; 105(12):1833-8. PubMed ID: 10862799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclast function in Paget's disease and multiple myeloma.
    Roodman GD
    Bone; 1995 Aug; 17(2 Suppl):57S-61S. PubMed ID: 8579899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies in Paget's disease and their relevance to oncology.
    Roodman GD
    Semin Oncol; 2001 Aug; 28(4 Suppl 11):15-21. PubMed ID: 11544571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
    Roodman GD; Kurihara N; Ohsaki Y; Kukita A; Hosking D; Demulder A; Smith JF; Singer FR
    J Clin Invest; 1992 Jan; 89(1):46-52. PubMed ID: 1729280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of bone.
    Stephens E; Roy M; Bisson M; Nguyen HD; Scott MS; Boire G; Bouchard L; Roux S
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165852. PubMed ID: 32485219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
    Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
    Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
    Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.
    Sambandam Y; Sundaram K; Saigusa T; Balasubramanian S; Reddy SV
    Bone; 2017 Aug; 101():236-244. PubMed ID: 28506889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paget's disease and osteoclast biology.
    Roodman GD
    Bone; 1996 Sep; 19(3):209-12. PubMed ID: 8873960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell biology of Paget's disease.
    Reddy SV; Menaa C; Singer FR; Demulder A; Roodman GD
    J Bone Miner Res; 1999 Oct; 14 Suppl 2():3-8. PubMed ID: 10510206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aged G Protein-Coupled Receptor Kinase 3 (Grk3)-Deficient Mice Exhibit Enhanced Osteoclastogenesis and Develop Bone Lesions Analogous to Human Paget's Disease of Bone.
    Rabjohns EM; Rampersad RR; Ghosh A; Hurst K; Eudy AM; Brozowski JM; Lee HH; Ren Y; Mirando A; Gladman J; Bowser JL; Berg K; Wani S; Ralston SH; Hilton MJ; Tarrant TK
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.
    Miyagawa K; Ohata Y; Delgado-Calle J; Teramachi J; Zhou H; Dempster DD; Subler MA; Windle JJ; Chirgwin JM; Roodman GD; Kurihara N
    JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32078587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
    Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
    J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
    Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
    J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62
    Daroszewska A; Rose L; Sarsam N; Charlesworth G; Prior A; Rose K; Ralston SH; van 't Hof RJ
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of serum cytokines and growth factors on osteoclast formation in Paget's disease.
    Neale SD; Schulze E; Smith R; Athanasou NA
    QJM; 2002 Apr; 95(4):233-40. PubMed ID: 11937650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology of Paget's disease and osteoclast abnormalities.
    Reddy SV
    J Cell Biochem; 2004 Nov; 93(4):688-96. PubMed ID: 15389972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.